Jamroziak, Krzysztof

• Vol 49, No 3 (2018) - Zalecenia Ekspertów/Experts' Guidelines
  Szczepienia ochronne u dorosłych chorych na nowotwory hematologiczne oraz u chorych z asplenią – zalecenia PTHiT i sekcji do spraw zakażeń PALG
  Abstract  PDF (Polish)
• Vol 49, No 3 (2018) - Praca Poglądowa/Review Article
  Nowe terapie w leczeniu szpiczaka z wysokim ryzykiem cytogenetycznym
  Abstract  PDF (Polish)
• Vol 49, No 4 (2018) - Zalecenia Ekspertów/Experts' Guidelines
  Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2018/2019
  Abstract  PDF (Polish)
• Vol 50, No 3 (2019) - Praca Poglądowa / Review Article
  Wyzwania wczesnej diagnostyki szpiczaka plazmocytowego – algorytm diagnostyczny
  Abstract  PDF (Polish)
• Vol 45, No 3 (2014) - Prace poglądowe/Reviews
  Diagnostic and therapeutic recommendations of the Polish Society of Hematology and Transfusion Medine and Polish Adult Leukemia Group – CLL for chronic lymphocytic leukemia in 2014
  Abstract  PDF (Polish)
• Vol 45, No 3 (2014) - Prace poglądowe/Reviews
  Efficacy of bortezomib in plasma cell myeloma with high-risk cytogenetic aberrations
  Abstract  PDF (Polish)
• Vol 44, No 1 (2013) - Zalecenia Ekspertów / Experts' Guidelines
  Guidelines of Polish Myeloma Group concerning diagnosis and therapy of multiple myeloma and other plasmacytic dyscrasias for 2013
  Abstract  PDF (Polish)
• Vol 44, No 1 (2013) - Prace oryginalne / Original research articles
  CD38 gene polymorphisms and genetic predisposition to multiple myeloma
  Abstract  PDF
• Vol 47, No 3 (2016) - Prace poglądowe / Reviews
  Diagnostic and therapeutic recommendations of the Polish Society of Hematology and Transfusion Medicine and Polish Adult Leukemia Group-CLL for chronic lymphocytic leukemia in 2016
  Abstract  PDF (Polish)
• Vol 47, No 3 (2016) - Prace oryginalne / Original research articles
  Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers
  Abstract  PDF (Polish)
• Vol 48, No 3 (2017) - Prace poglądowe / Reviews
  Ixazomib in patients with relapsed/refractory multiple myeloma
  Abstract  PDF (Polish)
• Vol 44, No 3 (2013) - Prace poglądowe / Reviews
  Cereblon: A molecular target of immunomodulatory drugs
  Abstract  PDF (Polish)
• Vol 43, No 1 (2012) - Experts’ Guidelines
  Recommendations of Polish Myeloma Group concerning diagnosis and therapy of multiple myeloma for 2012
  Abstract  PDF (Polish)
• Vol 45, No 1 (2014) - Artykuły redakcyjne / Editorials
  Bortezomib in combination therapy: two, three or four drugs?
  Details  PDF (Polish)
• Vol 48, No 2 (2017) - Prace poglądowe / Reviews
  Recommendations of Polish Myeloma Group concerning diagnosis and therapy of multiple myeloma and other plasmacytic dyscrasias for 2017
  Abstract  PDF (Polish)
• Vol 47, No 2 (2016) - Prace poglądowe / Reviews
  Recommendations of Polish Myeloma Group concerning diagnosis and therapy of multiple myeloma and other plasmacytic dyscrasias for 2016
  Abstract  PDF (Polish)
• Vol 47, No 4 (2016) - Errata / Erratum
  Retrospective analysis of nilotinib and dasatinib efficacy in second line treatment of chronic myeloid leukemia in Polish hematological centers [Acta Haematologica Polonica 2016; 47(3): 219–225]
  Details  PDF (Polish)
• Vol 48, No 4 (2017) - Prace oryginalne / Original research articles
  Analysis of ibrutinib efficacy in a subgroup of chronic lymphocytic leukemia patients with 17p deletion: observational study of the Polish Adult Leukemia Group (PALG)
  Abstract  PDF (Polish)
• Vol 46, No 3 (2015) - Prace poglądowe / Reviews
  Recommendations of Polish Myeloma Group concerning diagnosis and therapy of multiple myeloma and other plasmacytic dyscrasias for 2015
  Abstract  PDF (Polish)
• Vol 46, No 3 (2015) - Prace poglądowe / Reviews
  Immunoglobulin replacement in patients with chronic lymphocytic leukemia and multiple myeloma
  Abstract  PDF (Polish)